cabri - that's the question that I asked in my july news? thread.As the offer is fully underwritten the company will be getting the cash anyway, so I feel that the next 3 weeks will be business as usual.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%